ATE431736T1 - Inhibitoren der löslichen adenylatzyklase - Google Patents

Inhibitoren der löslichen adenylatzyklase

Info

Publication number
ATE431736T1
ATE431736T1 AT06762012T AT06762012T ATE431736T1 AT E431736 T1 ATE431736 T1 AT E431736T1 AT 06762012 T AT06762012 T AT 06762012T AT 06762012 T AT06762012 T AT 06762012T AT E431736 T1 ATE431736 T1 AT E431736T1
Authority
AT
Austria
Prior art keywords
soluble
adenyl cyclase
cyclase inhibitors
inhibitors
adenyl
Prior art date
Application number
AT06762012T
Other languages
English (en)
Inventor
Bernd Buchmann
Duy Nguyen
Martin Fritsch
Bernd Menzenbach
Ulf Boemer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of ATE431736T1 publication Critical patent/ATE431736T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
AT06762012T 2005-06-08 2006-06-07 Inhibitoren der löslichen adenylatzyklase ATE431736T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005027274A DE102005027274A1 (de) 2005-06-08 2005-06-08 Inhibitoren der löslichen Adenylatzyklase
PCT/EP2006/005608 WO2006131398A2 (en) 2005-06-08 2006-06-07 Inhibitors of soluble adenylate cyclase

Publications (1)

Publication Number Publication Date
ATE431736T1 true ATE431736T1 (de) 2009-06-15

Family

ID=37398540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06762012T ATE431736T1 (de) 2005-06-08 2006-06-07 Inhibitoren der löslichen adenylatzyklase

Country Status (23)

Country Link
EP (1) EP1888058B1 (de)
JP (1) JP2008542422A (de)
KR (1) KR20080016617A (de)
CN (1) CN101193631A (de)
AR (1) AR054378A1 (de)
AT (1) ATE431736T1 (de)
AU (1) AU2006256857A1 (de)
BR (1) BRPI0610934A2 (de)
CA (1) CA2606692A1 (de)
CR (1) CR9578A (de)
DE (2) DE102005027274A1 (de)
DO (1) DOP2006000130A (de)
EA (1) EA200702590A1 (de)
EC (1) ECSP078024A (de)
GT (1) GT200600244A (de)
IL (1) IL186914A0 (de)
MX (1) MX2007015493A (de)
NO (1) NO20080104L (de)
PE (1) PE20061488A1 (de)
TW (1) TW200716090A (de)
UY (1) UY29583A1 (de)
WO (1) WO2006131398A2 (de)
ZA (1) ZA200800153B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006014319B4 (de) * 2006-03-23 2009-01-08 Bayer Schering Pharma Aktiengesellschaft Inhibitoren der löslichen Adenylatzyklase
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635776B1 (fr) * 1988-09-01 1993-06-11 Rhone Poulenc Agrochimie Derives amides, procede pour leur fabrication et compositions fongicides les contenant
US20020064849A1 (en) * 2000-09-05 2002-05-30 Herr John C. Human soluble testicular adenylyl cyclase
OA12626A (en) * 2001-06-28 2006-06-13 Pfizer Prod Inc triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP)and/or apolipoprotein B(APO B) secretion.
CN1578663B (zh) * 2001-09-14 2011-05-25 梅特希尔基因公司 组蛋白脱乙酰化酶抑制剂
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
EP1663242B1 (de) * 2003-08-07 2011-04-27 Rigel Pharmaceuticals, Inc. 2,4-pyrimidindiamin-verbindungen und verwendungen als antiproliferative mittel
CA2542096A1 (en) * 2003-10-09 2005-04-21 Aton Pharma, Inc. Thiophene and benzothiophene hydroxamic acid derivatives
EP1706114B1 (de) * 2004-01-21 2012-12-26 Cornell Research Foundation, Inc. Chemische inhibitoren löslicher adenylylcyclase (sac)
AU2005225471B2 (en) * 2004-03-26 2011-05-12 Methylgene Inc. Inhibitors of histone deacetylase
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
IL186914A0 (en) 2008-02-09
BRPI0610934A2 (pt) 2010-08-03
NO20080104L (no) 2008-03-03
DOP2006000130A (es) 2006-11-30
GT200600244A (es) 2007-01-23
EP1888058B1 (de) 2009-05-20
ZA200800153B (en) 2009-03-25
AU2006256857A1 (en) 2006-12-14
CA2606692A1 (en) 2006-12-14
PE20061488A1 (es) 2007-02-03
WO2006131398A3 (en) 2007-04-19
EA200702590A1 (ru) 2008-06-30
AR054378A1 (es) 2007-06-20
ECSP078024A (es) 2008-01-23
DE102005027274A1 (de) 2006-12-14
UY29583A1 (es) 2007-01-31
JP2008542422A (ja) 2008-11-27
EP1888058A2 (de) 2008-02-20
TW200716090A (en) 2007-05-01
WO2006131398A2 (en) 2006-12-14
CN101193631A (zh) 2008-06-04
DE602006006908D1 (de) 2009-07-02
KR20080016617A (ko) 2008-02-21
MX2007015493A (es) 2008-02-22
CR9578A (es) 2008-03-06

Similar Documents

Publication Publication Date Title
ATE400271T1 (de) Aryl-pyridinderivate als 11-beta-hsd1-hemmer
ATE420076T1 (de) Indozolonderivate als 11b-hsd1-inhibitoren
DK1966151T3 (da) Polycykliske indazolderivater, der er ERK-hæmmere
CR10369A (es) Pyrimidine derivatives as pi3k inhibitors
ATE520671T1 (de) Pyrimidin-harnstoff-derivate als kinase-hemmer
DK2094263T3 (da) 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
NL2000537A1 (nl) Aminederivaten.
DK1846394T3 (da) Pyrazolylaminopyridinderivater, der er egnede som kinaseinhibitorer
ATE483711T1 (de) Spiroindolinonderivate
ATE383361T1 (de) Pyrrazolopyrimidinderivate
DK1725553T3 (da) Tetrahydropyridoindolderivater
ATE540935T1 (de) Chinazolinderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
IL189048A (en) Uranium derivatives as 3-gsk inhibitors
DK2142514T3 (da) Thioureaderivater som glutaminylcyclase-inhibitorer
ATE417830T1 (de) Sulfonylbenzimidazolderivate
DK2160389T3 (da) Thioxoquinazolinonderivater som glutaminylcyclaseinhibitorer
DK2160380T3 (da) Cyano-guanidin derivater som glutaminyl cyclase inhibitorer
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
DE602006017741D1 (de) Azaindol-2-carboxamid-derivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties